2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …
K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
Primary stroke prevention worldwide: translating evidence into action
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …
worldwide and its burden is increasing rapidly in low-income and middle-income countries …
[HTML][HTML] Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Stroke Collaborators - The Lancet. Neurology, 2019 - ncbi.nlm.nih.gov
Background Stroke is a leading cause of mortality and disability worldwide and the
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Background Stroke is a leading cause of mortality and disability worldwide and the
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies
Introduction Unhealthy lifestyles caused a huge disease burden. Adopting healthy lifestyles
is the most cost-effective strategy for preventing non-communicable diseases. The aim was …
is the most cost-effective strategy for preventing non-communicable diseases. The aim was …
Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence …
EA O'Connor, CV Evans, MC Rushkin, N Redmond… - Jama, 2020 - jamanetwork.com
Importance Cardiovascular disease is the leading cause of death in the US, and poor diet
and lack of physical activity are major factors contributing to cardiovascular morbidity and …
and lack of physical activity are major factors contributing to cardiovascular morbidity and …
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
JD Schwalm, T McCready, P Lopez-Jaramillo, K Yusoff… - The Lancet, 2019 - thelancet.com
Background Hypertension is the leading cause of cardiovascular disease globally. Despite
proven benefits, hypertension control is poor. We hypothesised that a comprehensive …
proven benefits, hypertension control is poor. We hypothesised that a comprehensive …
[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …